Reuters: J&J chief gets president's ear on job growth

Johnson & Johnson ($JNJ) CEO Bill Weldon (photo) is among the corporate executives set to meet with President Obama Friday afternoon to talk about economic woes and prospects for job creation, sources tell Reuters. Report

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Since the Warp Speed selections went public, experts have been wondering why some drugmakers were left off.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.